SYS | | c025887 |
LBL | | ^^^^^nam^^22^^^^^^^^450^ |
005 | | 20130408173324.7 |
100 | | $a 20001023d2000 m y0sloc0103 ba |
101 | 0- | $a eng |
102 | | $a GB |
105 | | $a a aozd100yy |
200 | 1- | $a Benefits of early anaemia treatment in patients with renal insufficiency $e 4 November 1999, Miami, Florida, USA $f Co-chairmen Garabed Eknoyan, J. F. E. Mann |
210 | | $a Oxford $c Oxford University Press $d 2000 |
215 | | $a 44 s. |
225 | 2- | $a Nephrology, Dialysis, Transplantation $v Suppl. 3 $x 0931-0509 |
541 | 1- | $a Výhody včasnej liečby anémie u pacientov s renálnou insuficienciou $e 4.11.1999, Florida, USA |
606 | | $3 sllk_un_auth*d051437 $a insuficiencia renálna $x patofyziológia $x terapia $2 mesh |
606 | | $a anémia $x terapia $x patofyziológia $2 mesh $3 sllk_un_auth*d000740 |
606 | | $a manažment choroby $2 mesh $3 sllk_un_auth*d019468 |
606 | | $a choroby obličiek $x terapia $2 mesh $3 sllk_un_auth*d007674 |
606 | | $a dialýza $2 mesh $3 sllk_un_auth*d003956 |
606 | | $a kvalita života $2 mesh $3 sllk_un_auth*d011788 |
606 | | $a urémia $x patofyziológia $x terapia $2 mesh $3 sllk_un_auth*d014511 |
606 | | $3 sllk_un_auth*d004921 $a erytropoetín $x farmakológia $x použitie terapeutické $2 mesh |
675 | | $a 616.61+616.15 $v 1. stred. $z slo |
702 | -1 | $a Eknoyan $b Garabed $3 sllk_un_auth*p0025990 $4 570 $p Houston, TX, USA |
702 | -1 | $a Mann $b Johannes F. E. $3 sllk_un_auth*p0025991 $4 570 $p Munich, Germany |
710 | 02 | $a European Renal Association $3 sllk_un_auth*k0000003 $4 070 |
711 | 02 | $a European Dialysis and Transplant Association $3 sllk_un_auth*k0000004 $4 070 |
801 | -0 | $a SK $b BA006 $c 20001023 $g AACR2 |